Taneja Rajesh
Pushpawati Singhania Research Institute--Surgical Division, New Delhi, India.
J Sex Med. 2007 Jul;4(4 Pt 2):1136-41. doi: 10.1111/j.1743-6109.2007.00507.x. Epub 2007 May 2.
Erectile dysfunction (ED) is a complex condition wherein men with minimal organic ED may develop a variable degree of psychogenic component sufficient to reduce the efficacy of medical management. A combination of trazodone with sildenafil has been used to overcome both organic as well as psychogenic components, thus improving the results of medical management.
To evaluate the efficacy of combination of trazodone with sildenafil citrate in treatment of ED in men with initial failure to sildenafil citrate alone.
The symptoms of ED were evaluated using the Erectile Dysfunction Intensity Scale (EDIS) before and after the treatment.
Eighteen men with ED who initially failed to respond to sildenafil citrate alone were enrolled in the study between February 2004 and December 2004. All these men were given a priming dose of trazodone for a 2-week period before giving them sildenafil citrate.
Of the 18 men, 12 responded favorably to the above treatment and continued to enjoy good sexual activity while on trazodone and sildenafil. The score on EDIS improved considerably in 12 (66.7%) men, marginally in two (11.1%) men, and did not improve at all in four (22.2%) men.
Priming the patients with trazodone appears to be a reasonably good alternative in patients who have initial failure to oral sildenafil citrate and have been found to have no organic cause of ED. However, large double-blind studies are required to potentiate this hypothesis.
勃起功能障碍(ED)是一种复杂的病症,其中患有轻度器质性ED的男性可能会出现不同程度的心理因素,足以降低药物治疗的效果。曲唑酮与西地那非联合使用可克服器质性和心理性因素,从而提高药物治疗的效果。
评估曲唑酮与枸橼酸西地那非联合治疗对单独使用枸橼酸西地那非初始治疗失败的男性勃起功能障碍的疗效。
治疗前后使用勃起功能障碍强度量表(EDIS)评估勃起功能障碍的症状。
2004年2月至2004年12月,18名单独使用枸橼酸西地那非初始治疗失败的勃起功能障碍男性纳入研究。所有这些男性在给予枸橼酸西地那非之前,先给予2周的曲唑酮初始剂量。
18名男性中,12名对上述治疗反应良好,在服用曲唑酮和西地那非期间继续享受良好的性活动。12名(66.7%)男性的EDIS评分显著改善,2名(11.1%)男性略有改善,4名(22.2%)男性完全没有改善。
对于单独口服枸橼酸西地那非初始治疗失败且未发现器质性勃起功能障碍病因的患者,先用曲唑酮治疗似乎是一个相当不错的选择。然而,需要大型双盲研究来证实这一假设。